CHEMPLASTS NSE filing

Chemplast Sanmar Long-Term Ratings Downgraded to 'A' by CRISIL

The RealCase readMedium impact Negative

CRISIL Ratings has downgraded Chemplast Sanmar Limited's long-term ratings from A+ to A, maintaining a Negative outlook. Short-term ratings are reaffirmed at A1. The total bank loan facilities remain ₹2,001 crore. The subsidiary, Chemplast Cuddalore Vinyls Limited, also saw its long-term ratings downgraded to A from A+.

Why it matters

A credit rating downgrade can impact borrowing costs and investor confidence, potentially affecting the company's ability to raise capital or its stock price. While the outlook remains negative, the reaffirmation of short-term ratings and unchanged facility quantum provide some stability.

The market read

The downgrade of long-term credit ratings by CRISIL indicates a perceived increase in risk or a deterioration in the company's financial health or future prospects.

Chemplast Sanmar Limited has announced a downgrade in its long-term credit ratings by CRISIL Ratings. The company's long-term ratings have been revised from 'A+' to 'A', with the outlook remaining Negative. Concurrently, the short-term ratings have been reaffirmed at 'A1'. The total quantum of bank loan facilities for Chemplast Sanmar Limited remains unchanged at ₹2,001 crore.

Similarly, its wholly-owned subsidiary, Chemplast Cuddalore Vinyls Limited, has also experienced a downgrade in its long-term ratings from 'A+' to 'A', maintaining a Negative outlook. The short-term ratings for the subsidiary have been reaffirmed at 'A1'. The quantum of bank loan facilities for Chemplast Cuddalore Vinyls Limited is also unaltered at ₹2,550 crore.

This information was officially released on March 26, 2026, at 11:41 AM IST. The rating rationale document published by CRISIL Ratings Ltd on the same date provides further details.

Filing to action

What to do with a filing like this

Chemplast Sanmar Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Chemplast Sanmar Limited. Read the original for the full detail.

View original filing